Table 1 Pretreatment Bcl-2/IgH level and... | American Society of Hematology

Table 1

Pretreatment Bcl-2/IgH level and clinical parameters

Parameters	n	Median Bcl-2/IgH level	P
Sex
Male	62	0.06335	.514
Female	45	0.221
Age >50 y
Yes	81	0.09845	.379
No	26	0.0359
Age >60 y
Yes	51	0.182	.609
No	56	0.0487
Age >65 y
Yes	33	0.0568	.683
No	74	0.10395
Ann Arbor stage
I-III	28	0.02785	.038
IV	78	0.318
BM involvement
Yes	66	0.4325	.007
No	38	0.01895
Spleen involvement
Yes	32	0.455	.015
No	64	0.0487
LN involvement >3
Yes	76	0.3285	.004
No	30	0.00621
LN involvement >5
Yes	48	0.6445	.001
No	58	0.02605
LN involvement >7
Yes	28	1	.033
No	78	0.04495
β2-microglobulin >3 mg/L
Yes	24	2	.026
No	55	0.0478
LDH >250 U/L
Yes	36	0.18445	.903
No	69	0.0487

Parameters	n	Median Bcl-2/IgH level	P
Sex
Male	62	0.06335	.514
Female	45	0.221
Age >50 y
Yes	81	0.09845	.379
No	26	0.0359
Age >60 y
Yes	51	0.182	.609
No	56	0.0487
Age >65 y
Yes	33	0.0568	.683
No	74	0.10395
Ann Arbor stage
I-III	28	0.02785	.038
IV	78	0.318
BM involvement
Yes	66	0.4325	.007
No	38	0.01895
Spleen involvement
Yes	32	0.455	.015
No	64	0.0487
LN involvement >3
Yes	76	0.3285	.004
No	30	0.00621
LN involvement >5
Yes	48	0.6445	.001
No	58	0.02605
LN involvement >7
Yes	28	1	.033
No	78	0.04495
β2-microglobulin >3 mg/L
Yes	24	2	.026
No	55	0.0478
LDH >250 U/L
Yes	36	0.18445	.903
No	69	0.0487